Search

everythinglearnresearchcommunity

for

Search:↓

RC48 shows promise for treating certain advanced cancers, but more research is needed.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

Low intensity ultrasound may reduce side effects of chemotherapy drugs like paclitaxel.

Albendazole and praziquantel can cause severe side effects, especially with prolonged use or liver issues.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Protoporphyrin IX is useful in cancer treatment but can cause health problems if not properly regulated.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

Chemotherapy provides symptom relief and extends life in 30-50% of gynecological cancer cases, but has only cured choriocarcinoma.

Anticancer drugs like methotrexate and trimetrexate could be effective and safe for treating malaria at low doses.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Scientists created a gel with nanoparticles to deliver medicine to hair follicles effectively.

FA-MNPs effectively targeted and killed cancer cells but didn't overcome drug resistance.

The combination treatment showed a higher response rate but no significant survival benefits.

New cancer treatments aim to reduce side effects and improve effectiveness.

Inhibiting ODC can prevent UV-induced skin cancer.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Topical vasoconstrictors do not reduce chemotherapy effectiveness against leukemia in mice.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

Minocycline reduces acne rash, pyridoxine lowers hand-foot syndrome risk, and scalp cooling lessens hair loss from cancer treatments.

DFMO may help control hair growth and treat cancer.